Mindray Revolutionizes the Way of Using Ultrasound with TE Air, Its First Wireless Handheld Ultrasound System

Mindray (SZSE: 300760), one of the world’s leading developers and providers of advanced medical devices and solutions, recently launched its first wireless handheld ultrasound system, the TE Air.

“Built from Mindray’s leading technologies, the TE Air has made a historic breakthrough in the image quality level of handheld ultrasound, integrating professional-level image quality into a small and light wireless system. Its premium performance and wireless portability allow clinicians to diagnose anytime and anywhere with confidence,” said Xujin He, General Manager of the Medical Imaging System Business Unit at Mindray.

Designed specifically to meet the demand of global healthcare professionals for a higher-quality portable ultrasound device that is easy to use in multiple medical environments and delivers crisp point-of-care ultrasound (POCUS) imaging, the TE Air revolutionizes the way of using ultrasound by transforming a complicated ultrasound system into a small size device, while retaining its ability to meet higher clinical requirements.

Powered by Mindray’s eWave platform and 2nd generation Single Crystal technology, the TE Air delivers high-quality images with low power consumption for ultimate performance. Meanwhile, with the features of dedicated exam presets and comprehensive imaging modes, the TE Air allows clinicians to conduct ultrasound examinations more efficiently and offers more accurate decision-making assistance.

The TE Air’s wire-free design and compact size that easily fits in a pocket, high-level disinfection tolerance, and flexible charging for extreme mobility, empower clinicians to overcome the challenges brought by unexpected mobile clinical scenarios. The unique Air Capsule doubles as a protective case and a portable wireless charger that keeps the device running all day, taking only 35 minutes to fast charge the device. With an IP68-level waterproof and dustproof design, the device is fully immersible for high-level disinfection, suitable for hospital infection control.

The TE Air App, available for Android and iOS, perfectly balances simplicity and efficiency by allowing one-handed operation in any location. The TE Air can connect with advanced devices such as the Mindray TEX20 Ultrasound System, enabling providers to overcome the limitations of cords and tight spaces while offering premium functionality. It can also seamlessly integrate with hospital information systems to help improve workflow. Furthermore, the de-identified data collected can be saved and shared to meet the needs of teaching, training, consultation, and case sharing.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”